1. Home
  2. NC vs PBYI Comparison

NC vs PBYI Comparison

Compare NC & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NACCO Industries Inc.

NC

NACCO Industries Inc.

HOLD

Current Price

$47.40

Market Cap

352.0M

Sector

Energy

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$7.93

Market Cap

403.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NC
PBYI
Founded
1913
2010
Country
United States
United States
Employees
N/A
179
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
352.0M
403.6M
IPO Year
2006
2011

Fundamental Metrics

Financial Performance
Metric
NC
PBYI
Price
$47.40
$7.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.9K
323.2K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
2.07%
N/A
EPS Growth
N/A
N/A
EPS
1.17
N/A
Revenue
$104,778,000.00
$27,685,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$40.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.43
$3.04
52 Week High
$59.42
$8.75

Technical Indicators

Market Signals
Indicator
NC
PBYI
Relative Strength Index (RSI) 40.07 45.30
Support Level $44.66 $7.64
Resistance Level $50.51 $7.83
Average True Range (ATR) 1.22 0.37
MACD 0.06 -0.08
Stochastic Oscillator 8.38 13.16

Price Performance

Historical Comparison
NC
PBYI

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments: Utility Coal Mining, Contract Mining, and Minerals and Royalties. The Utility Coal Mining segment, operated by North American Coal, manages surface coal mines that are exclusive, long-term fuel providers for power generation companies. The Contract Mining segment, operated by North American Mining, is a provider of a broad range of specialized, long-term contract mining services. The Minerals and Royalties segment, which includes the Catapult Mineral Partners (Catapult) business, acquires and promotes the development of mineral and royalty interests and other related investments.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: